Comments
Loading...

Vivos Therapeutics

VVOSNASDAQ
Logo brought to you by Benzinga Data
$3.97
0.041.02%
At close: -
$3.98
0.010000.25%
After Hours: 5:56 PM EDT

Vivos Therapeutics (NASDAQ:VVOS) Stock, Earnings Estimates, EPS, And Revenue

Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 27
EPS Estimate
$-0.430
Quarterly Revenue Estimate
$3.89M
Annual Revenue
(as of Sep 30)
$14.58M

Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Vivos Therapeutics (VVOS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-14$-0.40$-0.7042.9 %
Q22024-08-14$-0.60$-1.0542.9 %
Q42024-03-28$-3.05$-1.90-60.5 %
Q22023-08-16$-4.50$-3.50-28.6 %

Vivos Therapeutics (VVOS) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-14$3.86M$4.18M-7.66 %
Q22024-08-14$4.05M$3.60M12.6 %
Q42024-03-28$3.25M$3.41M-4.75 %
Q22023-08-16$3.40M$4.15M-18.2 %

FAQ

Q

When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?

A

Vivos Therapeutics (VVOS) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Vivos Therapeutics (NASDAQ:VVOS)?

A

The Actual EPS was $-0.40, which beat the estimate of $-0.70.

Q

What were Vivos Therapeutics’s (NASDAQ:VVOS) revenues?

A

The Actual Revenue was $3.9M, which missed the estimate of $4.2M.

Browse earnings estimates, EPS, and revenue on all stocks.